LYRA THERAPEUTICS announces additional data presentations FROM PHASE 2 LANTERN STUDY at the americal rhinologic society annual meeting
Stock Information for Lyra Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.